Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2025 17:50 ET | Source: Robbins LLP

Robbins LLP Reminds NUTX Investors with Large Losses of the Pending Class Action Against Nutex Health Inc. and Urges Stockholders to Contact the Firm for More Information

Robbins LLP is Investigating Allegations that Nutex Health Inc. (NUTX) Failed to Disclose Fraud Committed by its Third-Party Arbitration Vendor
September 02, 2025 17:41 ET | Source: Robbins LLP

LFMD Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the LifeMD, Inc. Securities Fraud Class Action

Robbins LLP is Investigating Allegations that LifeMD, Inc. (LFMD) Misled Investors Regarding its Business Prospects
August 14, 2025 19:22 ET | Source: Robbins LLP

ANRO Investors: If You Have Suffered Large Losses Contact Robbins LLP for Information About Leading the Alto Neuroscience, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Alto Neuroscience, Inc. (ANRO) Misled Investors Regarding the Viability of its Drug Candidate
June 03, 2025 17:11 ET | Source: Robbins LLP

OGN Stock Alert: Organon & Co. Shareholders with Large Losses Should Contact Robbins LLP for Information on Leading the Class Action Lawsuit

Robbins LLP is Investigating Allegations that Organon & Co. (ORG) Misled Investors Regarding its Debt Reduction Strategy
June 02, 2025 19:36 ET | Source: American Board of Obstetrics and Gynecology

Clarifying ABOG's Mission and the Certification Process

Dallas, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) acknowledges the perspectives and concerns raised by attorneys general regarding the safety...
May 14, 2025 08:00 ET | Source: BetterLife Pharma Inc.

BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on...
February 13, 2025 19:52 ET | Source: Robbins LLP

Icon PLC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Stockholders of the Class Action Against ICLR

Robbins LLP is Investigating Allegations that ICON PLC (ICLR) Misled Investors Regarding Demand
November 25, 2024 08:00 ET | Source: BetterLife Pharma Inc.

BetterLife Obtains Favourable Cardiac Safety Data for BETR-001

VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
June 05, 2024 16:10 ET | Source: Robbins LLP

EXAI STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Exscientia plc Class Action

Robbins LLP is Investigating the Allegations that Exscientia plc's (EXAI) Former CEO's Conduct Violated the Company's Code of Business Conduct
May 15, 2024 14:43 ET | Source: Robbins LLP

Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action

Robbins LLP is Investigating the Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability and Efficacy of its Weight Loss Drug